We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Final PAS and DMF Guidances as GDUFA II Gets Underway
FDA Issues Final PAS and DMF Guidances as GDUFA II Gets Underway
Following the launch of GDUFA II Oct. 1, the FDA released final guidances and timelines for reviewing generic prior approval supplements and API drug master files.